PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1408722
PUBLISHER: UnivDatos Market Insights Pvt Ltd | PRODUCT CODE: 1408722
A laryngoscope blade is a medical device used in conjunction with a laryngoscope handle during intubation procedures. It helps visualize the larynx by lifting the tongue and epiglottis, allowing a clear passage for intubation. Blades come in various shapes and sizes to accommodate different patient anatomies and clinical needs. The laryngoscope blade market is growing at a tremendous rate owing to a surge in the number of chronic diseases such as lung and throat cancer. For instance, in 2020, the International Agency for Research on Cancer and the World Health Organization conducted a GLOBOCAN study on global cancer incidence and prevalence. According to the results of the study, there were approximately 308,102 new cases diagnosed in the U.S. Other factors such as increased focus on early detection and prevention, advances in diagnostics, rising product launch and product approval for laryngoscope systems, and a rise in the senior population are driving factors for the market.
The Laryngoscope Blades Market is expected to grow at a strong CAGR of 5.1% during the forecast period owing to the rising product approvals for finding a potential diagnostic system. For instance, in July 2022, a leading developer of high-performance, single-use endoscopes Zsquare, got FDA clearance to market its first product, the Zsquare ENT-Flex Rhinolaryngoscope. Several other factors such as an increased number of product launches, investment in research, improved patient outcomes, and company collaborations are also leading to the surge in the market. For instance, PROACT Medical launched an innovative new line of single-use laryngoscopes in the European market in November 2022.
Based on types, the market is bifurcated into straight blade and curved blade. The curved blade segment held the highest share in the market in the year 2022 owing to its narrower flange which can control the tongue and decrease trauma to the gingiva and teeth. This type of blade is more suitable for older children. The increased need for minimally invasive diagnostics and innovative product launches have led to significant growth in this segment. Hence, the curved blade segment held a significant share of the market in the year 2022.
Based on usability, the market is bifurcated into disposable, and reusable. The reusable segment is expected to grow with the highest CAGR during the forecast period. This growth is attributed to the cost efficiency and longer life cycle of the reusable blades. This segment is gaining market dominance due to an adaptation of a bad lifestyle comprising of smoking and alcohol that has increased the incidences of throat and lung cancers, and increased awareness of chronic conditions such as lung and throat cancer. For instance, the American Cancer Society estimates that in 2022, there will be about 12,470 new cases of laryngeal cancer including 9,820 men and 2,650 women in the U.S. Thus, the reusable segment is expected to gain prominence in the market in the forecast period.
Based on end-users, the market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals category held the highest share in the market in 2022 attributed to the ease of access to healthcare provided by hospitals, the availability of highly qualified healthcare personnel, the utilization of advanced medical technology, and a diverse number of units all over the globe. For instance, according to the American Hospital Association in 2023, there are in total of 6,129 hospitals in the U.S with 919,649 staffed beds and 34,011,386 hospital admissions in the year 2022. The market for the hospital segment is highly competitive and is projected to remain so in the foreseeable future. Thus, the hospital segment held dominance in the market in the year 2022.
For a better understanding of the market adoption of the laryngoscope blades industry, the market is analyzed based on its worldwide presence in countries such as North America (U.S., Canada, and Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is expected to grow with the highest CAGR during the forecast period. This is due to the presence of major players in the market, the increasing incidence of cancers, and the presence of well-established academic and research institutes. Countries such as India and China offer attractive investment opportunities for clinical research and are anticipated to positively drive research and development prospects for laryngoscope blades. Hence, given the large population size of APAC, it is expected to grow with a high CAGR during the forecast period.
Some of the major players operating in the market include: Teleflex Incorporated; Olympus Corporation; Ambu A/S; HOYA Corporation; Stryker; Henke Sass Wolf GmbH; FUJIFILM Corporation; Hartwell Medical LLC; Medtronic; Smiths Group plc.